Summary
In the AEGEAN study, the addition of an education program to apixaban therapy in patients with atrial fibrillation did not improve patient adherence or persistence to therapy at 24 weeks. The rates of adherence and persistence were high.
- atrial fibrillation
- apixaban
- NOAC
- adherence
- persistence
- cardiology & cardiovascular medicine clinical trials
- arrhythmias
- © 2015 SAGE Publications
Tools
Table of contents
Cited By...
- No citing articles found.